Show simple item record

Durvalumab in Stage III Non-Small-Cell Lung Cancer

dc.contributor.authorSantoni, Matteo
dc.contributor.authorButi, Sebastiano
dc.contributor.authorBattelli, Nicola
dc.date.accessioned2021-03-03T14:59:16Z
dc.date.available2021-03-03T14:59:16Z
dc.date.issued2018
dc.identifier.citationSantoni M., Battelli N., Buti S., "Durvalumab in Stage III Non-Small-Cell Lung Cancer", NEW ENGLAND JOURNAL OF MEDICINE, cilt.378, sa.9, ss.869, 2018
dc.identifier.issn0028-4793
dc.identifier.othervv_1032021
dc.identifier.otherav_3c96ccf4-7116-445a-b939-f77abbbee4e8
dc.identifier.urihttp://hdl.handle.net/20.500.12627/44648
dc.identifier.urihttps://doi.org/10.1056/nejmc1716426
dc.language.isoeng
dc.subjectTemel Tıp Bilimleri
dc.subjectTIP, GENEL & İÇECEK
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.titleDurvalumab in Stage III Non-Small-Cell Lung Cancer
dc.typeMakale
dc.relation.journalNEW ENGLAND JOURNAL OF MEDICINE
dc.contributor.departmentMacerata Hosp , ,
dc.identifier.volume378
dc.identifier.issue9
dc.identifier.startpage869
dc.identifier.endpage869
dc.contributor.firstauthorID252047


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record